SUDA Pharmaceuticals appoints a cellular immunotherapies expert to its scientific advisory board
With the appointment of Dr Reuben Benjamin, who leads the plasma cell disorder service and CAR-T cell program at King’s College, the company will gain...
Source: proactiveinvestors.com.au